OBJECTIVE
To review the existing data on use of the rifamycin class of antibiotics as therapy for Clostridium difficile-associated diarrhea (CDAD).
METHODS
A literature search was performed using PubMed (1996-January 2008), abstracts from the International Conference on Antimicrobial Agents and